Topics

ViiV Healthcare secures Japanese approval for Dovato to treat HIV-1 infection

02:25 EST 16 Jan 2020 | Pharmaceutical Business Review

The Japan Ministry of Health, Labour and Welfare (MHLW) has approved Dovato to treat HIV-1 infection in adults and adolescents above12 years of age with a minimum of

The post ViiV Healthcare secures Japanese approval for Dovato to treat HIV-1 infection appeared first on Pharmaceutical Business review.

Original Article: ViiV Healthcare secures Japanese approval for Dovato to treat HIV-1 infection

NEXT ARTICLE

More From BioPortfolio on "ViiV Healthcare secures Japanese approval for Dovato to treat HIV-1 infection"

Quick Search

Relevant Topic

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...